Clinical outcome according to tumor HER2 status and EGFR expression in advanced gastric cancer patients from the EXPAND study.

Authors

Florian Lordick

Florian Lordick

University Cancer Center Leipzig, Leipzig, Germany

Florian Lordick , Yoon-Koo Kang , Pamela Salman , Sang Cheul Oh , Gyorgy Bodoky , Galina Petrova Kurteva , Constantin D. Volovat , Vladimir Moiseyenko , Akira Sawaki , Joon Oh Park , Vera A. Gorbunova , Heiko Goette , Helena Melezinkova , Christopher Stroh , Markus Moehler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

2007-004219-75

Citation

J Clin Oncol 31, 2013 (suppl; abstr 4021)

DOI

10.1200/jco.2013.31.15_suppl.4021

Abstract #

4021

Poster Bd #

13

Abstract Disclosures